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Abstract Two isoforms of troponin C (TnC) are encoded by 
distinct single copy genes. Expression of fast TnC is restricted to 
the skeletal muscle, whereas the slow isoform is expressed in both 
skeletal and cardiac muscle. Chicken slow TnC (cTnC) gene is 
also expressed in some non-muscle tissues like the liver and the 
brain. Expression of cTnC gene is regulated by two distinct 
enhancers in cardiac and skeletal muscles. The cardiac specific 
enhancer is located in the immediate 5' flanking region (bp -124 
to -79)  of the murine cTnC gene whereas the skeletal enhancer 
is located within the first intron (bp 997 to 1141). In the present 
study we have examined how cTnC gene expression is regulated 
in the chicken liver. Transient transfection of liver cells with 
cTnC-CAT reporter constructs containing various regions of the 
marine eTnC gene showed that its expression in chicken liver is 
regulated by the cardiac specific enhancer. Furthermore, 
electrophoretic mobility shift assays using synthetic oligonucleo- 
tides corresponding to both CEF-1 and CEF-2 regions of the 
murine cardiac enhancer revealed formation of specific DNA- 
protein complexes. Ultraviolet light induced covalent linking of 
nuclear proteins to CEF-1 and CEF-2 oligomers were used to 
examine the nature of the cardiac enhancer binding polypeptides; 
one polypeptide of 48 kDa appeared to bind to both CEF-1 and 
CEF-2 sequences. 
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1 Introduction 
Contractile proteins are usually expressed in a tissue specific 
manner [1]. However, separate isoforms of a number of con- 
tractile proteins including actin, dystrophin, myosin and tro- 
p,)myosin occur in non-muscle tissues [2-6]. The non-muscle 
isoforms of these proteins arise from separate gene families 
aad have distinct regulatory mechanisms [7-10]. In most ani- 
n als the Troponin family (Troponin I, Troponin T and Tro- 
ponin C) proteins are expressed only in striated muscles 
[11,12]. These members encode functionally interacting subu- 
n ts of the calcium regulatory troponin complex. Troponin C 
(' "nC) is the calcium binding subunit of the troponin complex. 
l~s two isoforms are separate gene products [13]. The fast TnC 
(,TnC) gene is exclusively expressed in the fast twitch skeletal 
n,uscles while the slow TnC (cTnC) gene is expressed exten- 
sively in cardiac and slow twitch skeletal muscles, and only 
t~ansiently in embryonic fast skeletal muscles [2,14,15]. These 
two isoforms have distinct differential expression mechanisms 
[11]. A core promoter and a transcriptional enhancer are lo- 
cated within the immediate flanking region (bp -124  to +32) 
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of the gene and function in a cardiac specific fashion [7]. In 
skeletal myotubes cTnC gene expression is under the control 
of an independent transcriptional enhancer positioned within 
the first intron (bp 997-1141). The cTnC protein has recently 
been detected in non-muscle tissues, e.g. human HeLa cells 
[16], chicken liver and brain [17]. However, the function and 
regulation of expression of this gene in non-muscle cells is still 
unknown. In the studies presented here we have examined 
how the cardiac cTnC gene is expressed in chicken liver. Since 
the chicken cTnC gene has not been characterized we have 
examined the mouse cardiac enhancer for its ability to express 
a reporter CAT gene in chicken liver hepatocytes in culture 
and to form specific nucleoprotein complexes with chicken 
liver and brain nuclear extracts. 
2. Materials and methods 
2.1. Cell cultures 
Primary cardiac myocyte cultures were prepared using 14-day em- 
bryonic hicken hearts as previously described [18,19]. In short, hearts 
from several embryos were minced into small pieces and digested with 
0.1% collagenase and 0.1% hyaluronidase. Fibroblasts from all these 
digestions were removed by differential centrifugation, while cardiac 
myocytes were pelleted at 3000xg for 5 rain. 2x 10~.m1-1 cardiac 
myocytes were plated in each well (2 cm 2) of a 12-well tissue culture 
plate (Nunc). Cells were maintained in Dulbecco's modified Eagle 
medium (DMEM, Gibco/BRL) containing glutamine, 10% equine ser- 
um, 3% fetal bovine serum, and 100 units/ml penicillin/100 gg/ml 
streptomycin. The medium was changed aily. Primary hepatocyte 
cultures were derived from 14-day-old embryonic hick liver [2], by 
dissociation ofcells with 0.1% trypsin in Hank's Balanced Salts (HBS) 
solution (Gibco) at 37°C for 15-30 min. Hepatocytes were grown as 
monolayer in gelatin-coated 12-well plates (2 cm 2) to a density of 
about 2-5x10 s cells.m1-1 in minimum essential Eagle's medium 
(MOD.) supplemented with 10% fetal bovine serum and antibiotics. 
The medium was changed aily. 
2.2. Nuclear extracts 
Nuclear extracts were prepared as previously described [20]. Var- 
ious tissues were dissected from 14-day-old chicken embryos, were 
rinsed and minced into small pieces in cold phosphate-buffered saline 
(PBS). Tissues were suspended infive volumes of hypotonic buffer { 10 
mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid), 
pH 7.9; 1.5 mM MgClz; 10 mM KC1; 0.5 mM DTT (dithiothreitol)} 
and kept for 20 min on ice. Tissues were homogenized with a Dounce- 
homogenizer until greater than 90% lysis of cells was achieved. The 
cell lysate was centrifuged at 3000xg for 5 min at 4°C to obtain 
nuclei. The nuclear pellet was washed once with PBS, resuspended 
in one volume of extraction buffer {20 mM HEPES, pH 7.9; 0.42 
M NaCI; 1.5 mM MgC12; 0.2 mM EDTA (disodium ethylenediami- 
netetraacetate); 0.5 mM phenyl-methylsulfonyl fluoride; 0.5 mM 
DTT and 20% glycerol} and incubated on ice for 30 min with inter- 
mittent mixing. Nuclear debris was removed by centrifugation at
12000xg for 10 min. The PBS and extraction buffers were supple- 
mented with protease inhibitors, Leupeptin (2 gg/ml), Aprotinin (2 I, tg/ 
ml) and Pefabloc (10 gg/ml). Supernatants were stored at -80"C until 
used. 
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2.3. Plasmids 
Plasmids containing the pCAT (chloramphenicol acetyltransferase 
gene) driven by various regions of murine cTnC gene were obtained 
from Dr. M.S. Parmacek, University of Chicago. Plasmid p2.2CAT 
had 2.2 kb BamHI-AluI cTnC genome fragment (bp -2200 to +32) 
subcloned into HindlII site of the pCAT-Basic (Promega) in a 5' to 3' 
orientation with respect o chloramphenicol acetyltransferase (CAT) 
gene; p-124CAT contained 156 bp Ball-AluI cTnC genomic fragment 
(bp -124 to +32) subcloned into HindlII-XbaI digested pCAT-Basic; 
p-79CAT had HindlII-XbaI-linked cTnC subfragment (bp -79 to 
+32) subcloned into HindlII-XbaI digested pCAT-Basic, pSPCA- 
T308ENH contained 308 bp cTnC PvulI genomic subfragment (bp 
881 to 1188) with cTnC skeletal muscle specific enhancer into BamHI 
site of the pSPCAT vector [7]. The pSMVI3gal [21] reference plasmid 
contained the [3-galactosidase g ne under the control of a long term- 
inal repeat from the Moloney murine sarcoma virus. 
2.4. Transfections and CA T assays 
Primary culture of neonatal murine cardiac myocytes, chicken em- 
bryonic (14 day) hepatocytes and cardiac myocytes were co- trans- 
fected with plasmids (containing various cTnC-CAT constructs) and 
pMSVl3gal reference plasmid using the cationic liposome (DOTAP) 
according to the manufacturer's (Boehringer Mannheim, Canada) in- 
structions. In short, 70% confluent cultures were used for transfection 
assays. The medium was changed 2-4 h prior to the transfection 
experiment. The transfection mixture was prepared by combining 15 
~tg pCAT plasmid DNA and 5 ~tg pMSV[3gal reference plasmid with 
15 ~tg of DOTAP in 150 I.tl of 20 mM HEPES (pH 7.4) buffer then 
incubated at room temperature for 10 min before diluting to 350 ~tl 
with culture medium containing 2% fetal bovine serum. Cells were 
treated with the transfection mixture for 16 h at 37°C in a humidified 
atmosphere of 5% CO2. Transfection mixture was then replaced with 
fresh culture medium which was changed aily. The cells were har- 
vested after 48 h. Cell extracts were prepared by repeated freeze/thaw- 
ing and CAT activity was measured by enzyme linked immunosorbent 
assay (CAT-ELISA) using a kit according to the manufacturer's 
(Boehringer Mannheim, Canada) instructions. Variations in transfec- 
tion efficiencies were corrected by assaying cell extracts for [3-galacto- 
sidase activities as previously described [7]. 
2.5. Electrophoretic mobility shift assay 
Oligonucleotides (Fig. 1) corresponding to CEF-1, mutant CEF-1 
(mCEF-1), CEF-2, mutant CEF-2 (mCEF-2), and a control oligonu- 
cleotide corresponding to muscle creatin kinase (MCK) enhancers 
were synthesized by DNAgency, Aston, USA. The CEF1 double- 
stranded oligonucleotide was labelled with [a-32p]GTP by fill-in reac- 
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tions using large Klenow fragment. Both strands of the CEF2 oligo- 
mer were separately 5'-end-labelled with [7-32p]ATP using T4 polynu- 
cleotide kinase, prior to annealing. Binding reactions, containing 0.5- 
1 ng radiolabelled probe (~ 103-104 cpm), 10-15 I.tg nuclear proteins, 
300 ng of poly(dI:dC), 10 mM Tris-HC1 (pH 7.9), 50 mM NaC1, 1 mM 
DTT, 1 mM EDTA and 4% Ficoll, were carried out on ice for 15 min. 
Competitions with unlabelled oligomers were performed by adding 
the competitor prior to incubation of the cell extract with the radi- 
olabelled probe. The reaction mixture was separated on a 5% non- 
denaturing polyacrylamide g l in 0.25 × TBE (I × TBE = 100 mM Tris 
pH 7.9, 100 mM boric acid and 2 mM EDTA) at 4°C. The gel was 
dried and the autoradiogram developed using Kodak X-omat RP film. 
2.6. Ultraviolet light-induced crosslinking of nuclear proteins to 
oligomers 
Double-stranded oligomers were labelled with 32p and incubated 
with nuclear extracts as previously described. The mixture was trans- 
ferred to a Parafilm sheet and exposed to a UV transilluminator (3000 
I.tW/cm 2) for 20 min. The samples were analyzed by electrophoresis in 
a 12% polyacrylamide g l in the presence of sodium dodecylsulphate 
(SDS) as previously described [22]. 
3. Results and discussion 
3.1. eTnC gene expression in chicken hepatocytes 
Studies from this laboratory have previously shown that the 
cTnC gene is expressed in the chicken liver and brain [17]. To 
examine the nature of the cis-regulatory sequences involved in 
regulating cTnC gene expression in chick liver, transient rans- 
fections of cells in culture were performed using cTnC-CAT 
reporter constructs (Fig. 2). Primary cultures of chicken he- 
patocytes, cardiac myocytes and mouse cardiac myocytes were 
transfected with various reporter plasmids. Results show that 
CAT expression was maximum in both chick liver and cardiac 
myocytes when -124pCAT was used for transfection. The 
level of CAT expression was also similar to that observed in 
murine cardiac myocyte culture (Fig. 2). In contrast he con- 
struct containing the skeletal muscle specific enhancer 
(pSPCAT308ENH) was unable to support CAT expression 
in these cells. The cardiac enhancer produced approximately 
60-90-fold increase of CAT expression compared to that of 
CARDIAC ENH 
CEF1 CEF2 CPF 1-3 
SKELETAL ENH 







5' -CCA GCC TGA GAT TAC AG -3' 
5' -CCA GCC AGA GAT CTC AGG GA -3' 
5' -GGT GGA GGA TAT TCC ACG -3' 
5' -GGT GCA GAT CTT TCC AGG -3' 
5' -CCC CCC CCC AAC ACC TGC TGC CTG A -3' 
Fig. 1. Structure and location of a cardiac and skeletal specific cTnC promoter/enhancer of the murine cTnC gene and the nucleotide sequence 
of the various oligomers used in these studies are shown. 
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the enhancerless CAT constructs in all three cell cultures tud- 
ied here. Results also show that presence of -79  to +32 re- 
gion of murine cTnC gene (p-79CAT) was insufficient to sup- 
pert CAT expression. It is interesting to note that the p- 
2.2CAT containing -2200 to +32 region of the murine 
c'l nC gene supported CAT expression only to an approxi- 
mately 10% level of that observed with p-124CAT. This ob- 
se~vation suggests the presence of negative regulatory ele- 
ments within this region. The results, therefore, indicate that 
the cardiac enhancer may be responsible for cTnC gene ex- 
pression in chicken liver. 
3.~!. CEF1 and CEF2 binding nuclear protein complexes in liver 
cells 
To detect he presence of nuclear proteins in liver cells that 
show specific binding to the cTnC transcriptional enhancer, 
s3/athetic oligonucleotides corresponding to the CEF-1 and 
CEF-2 regions of the murine cTnC gene [7] were used in 
EMSAs (Fig. 1). Results show that the CEF-1 (Fig. 3A) oli- 
gcmer forms two major complexes with chicken liver nuclear 
ex tract. One of these complexes displays mobility shifts corre- 
sponding to the major band formed with chicken heart nucle- 
ar extract. The faster migrating second band was only a minor 
component in the sample containing chicken heart extract. 
SiTnilar complexes were observed with the chicken brain nu- 
cl,'ar extract. A few additional bands were also shared be- 
tween the liver and brain extracts. These liver and cardiac 
m lscle specific bands also exhibited ose-dependent competi- 
ti~,n with the unlabelled CEF-1 oligomer. In contrast he mu- 
tant mCEF-1 oligomer was less efficient in the competition 
assays (Fig. 3B). In these studies nuclear extracts from new- 
born mouse heart showed only weak enhancer binding activ- 
ities (Fig. 3A, lane 5). However, the major nucleoprotein com- 
plexes formed using chicken and mouse cardiac and chicken 
liver and brain nuclear extracts were similar and distinct from 
those formed with the chicken skeletal muscle nuclear extract 
(Fig. 3A, lane 7). Electrophoretic mobility shift experiments 
were also performed with the radiolabelled CEF-2 oligomer. 
Results (Fig. 3C and D) show that three distinct nucleoprotein 
complexes were formed with both chicken heart and liver 
extracts. One of these complexes appeared to be the most 
prominent and was also formed with chicken brain and mur- 
ine heart nuclear extracts. Murine cardiac nuclear extracts 
also produced an additional presumably non-specific complex 
common to both C2C12 myotube and chicken skeletal muscle 
nuclear extract preparations. Formation of the major nucleo- 
protein complexes with heart, liver and brain extracts was 
similar to that reported previously [7]. To further assess the 
specificity of these interactions competition analyses were per- 
formed using unlabelled oligomers in excess. Results (Fig. 3D) 
show that the formation of these complexes was inhibited by 
the unlabelled CEF-2 oligomer. The mutant (mCEF-2) oligo- 
mer was unable to abolish formation of these complexes even 
when a 50-fold molar excess of unlabelled oligomer was used. 
The results of these studies using both CEF-1 and CEF-2 
oligomers, therefore, suggest that chicken liver, brain and 
heart contain similar nuclear proteins that bind to the cardiac 
specific enhancer sequence of the cTnC gene. 
eTnC Premier 
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cTnC promoter/enhancer constructs 
Fig. 2. Relative transcriptional activities of cTnC promoter/enhancer onstructs in transfected cells. CAT-ELISA of cellular extracts were per- 
formed after transient transfection with DNA constructs listed as described in Materials and methods. CAT-activity values were corrected for 
the difference in transfection efficiencies using 13-gal expression levels as controls. 
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Since electrophoretic mobility shift experiments reveal for- 
mation of specific DNA-protein complexes with both CEF-1 
and CEF-2 oligomers and the chick liver extract we attempted 
to further characterize the polypeptides of these complexes by 
covalently joining the DNA and proteins using UV-crosslink- 
ing. Radiolabelled oligomer linked polypeptides were then ex- 
amined by gel electrophoresis and autoradiography. These 
analyses how (Fig. 4A) the presence of one major polypep- 
tide of approximately 62 kDa and an additional minor band 
representing a polypeptide of 65 kDa in crosslinked prepara- 
tions using the CEF-1 oligomer. Appearance of these bands 
was also dependent upon UV-treatment of the reaction mix- 
ture (compare lanes 1 and 2). Formation of the labelled 62 
and 65 kDa bands was efficiently blocked by the presence of 
unlabelled CEF-1 oligomer but not by mutant or MCK oli- 
gomers. Since the oligomer of approximately 14 kDa was 
covalently linked to the polypeptides, the approximate mole- 
cular mass of the CEF-1 binding polypeptide was determined 
to be 48 kDa. It is interesting to note that recent studies have 
Ol~omer CEF 
Compet~or 
F~t  CH CL HEP MH C.,B 
shown that a GATA-4 transcription factor of 48 kDa which 
binds to the CEF-1 region of the mouse cTnC gene is required 
for its activation [23,24]. Members of the GATA-4 family of 
factors are also expressed in chicken heart and liver; there- 
fore, it is possible that expression of chicken cTnC gene is 
similarly regulated. 
Similar crosslinking studies using CEF-2 oligomer and 
chicken liver nuclear extract illustrate (Fig. 4B) the presence 
of two prominent and a number of minor bands representing 
different polypeptides covalently linked to the CEF-2 se- 
quence. Covalent linking of these polypeptides was specific 
to the CEF-2 sequence as this interaction was not blocked 
by either mutant CEF-2 or the MCK oligomer. Substraction 
of the molecular weight of the oligomer from these bands 
suggests that the major band (arrow) also represents a poly- 
peptide of 48 kDa. It should be noted that this molecular 
weight of one of the polypeptides is similar to that of 
GATA-4. Further studies are required, however, to character- 
ize the chick liver CEF-1 and CEF-2 cis-regulatory sequence 
. . . . . .  
!!ii!~i 
CEF1 -,  
CEF1 CEF1 mCEF1 
XlO XSD XSO 
CH CL CL CL CL CS 
1 2 3 4 5 6 7 1 2 3 4 5 6 
A B 
OIIgomer CEF2 CEF2 
Competitor . CEF2CEF2CE~CEF2mCEF2rnCEF2 
X10 X20 X50 XlO Y~O XSO 
Extract OH CL MH C2 CS CB CL CL CL CL CL CL GL 
1 2 3 4 5 6 7 1 2 3 4 5 6 7 8 
C D 
Fig. 3. EMSA analysis of the cardiac specific enhancer of murine cTnC gene. Examination of nuclear protein complexes binding to either 
CEF-1 (A and B) or to the CEF-2 (C and D) oligomers. Binding reactions and gel electrophoresis were performed as described in Materials 
and methods. Binding reaction was carried out with 0.5 ng of a2p-labelled oligomer and 15 ktg of nuclear extract. Nuclear extracts from 14- 
day-old embryonic chicken liver (CL), chicken heart (CH), chicken brain (CB) and chicken skeletal muscle (CS) were used. Newborn mouse 
heart (MH) was used for the preparation of MH nuclear extracts. Hepatocytes culture (HEP) from 14-day chick embryo was used for prepar- 
ing nuclear extract [18,19] as described in Materials and methods. In some xperiments (C and D) the binding reaction mixture contained indi- 
cated excess of unlabelled competitor oligomers. 
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Oligomer CEF1 
Competitor CEF1 rnCEF1 MCK 
XIO0 XlO0 XlO0 
Extract CL CL CL CL CL 
CEF2 
CEF2 rnCEF2 MCK 
XIO0 XIO0 XIO0 
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Fig. 4. UV-induced crosslinking of nuclear proteins to cardiac enhancer of murine cTnC gene. Radiolabelled double-stranded CEF-I or CEF-2 
oligonucleotide was mixed with the nuclear extract and subjected to UV treatment as described in Materials and methods. The samples were 
then analyzed by polyacrylamide g l electrophoresis n the presence of SDS [22]. CEF-1 oligomer (A), CEF-2 oligomer (B). The molecular 
wt'~ght standards are shown on the right hand side of each panel. 
binding proteins. Studies using chicken heart and brain nucle- 
ar extracts also produced similar results (not shown). 
Unlike other muscle proteins TnC, an important member of 
th~z contractile protein family, has not been found in all non- 
mLtscle cells. Of the two TnC isoforms, cTnC mRNA was 
previously reported in human fibroblast [16], while none of 
tht: murine non-muscle tissue revealed its existence [15]. Bere- 
zowsky and Bag (1992) reported the presence of cTnC mRNA 
in chicken liver and brain. Our results suggest hat chicken 
en',bryonic hepatocytes may employ sequences similar to the 
murine cardiac myocytes cis-regulatory elements to bind to 
tr~nscription factors for controlling cTnC gene expression. 
Since chicken cTnC gene has not been characterized, it will 
be essential to confirm these observations using the homolo- 
gous gene when it becomes available. Furthermore, the func- 
tk~n of cTnC in chicken liver is also unknown. One possibility 
is lhat it might act as a regulatory subunit of phosphorylase 
kiuase [25-27], whose activity is Ca 2+ dependent, and TnC, 
al,,ne or as part of the troponin complex, may serve as its 8- 
su!~unit [25,28,29]. 
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